A number of histopathological studies have found that the CP in people with MS (pwMS) is characterized by several changes, including the selective loss of tight junction protein claudin-3 [8], accumulation of granulocytes and T cells, [9] intense human leukocyte antigen-DR staining, [10] and substantial inflammation [11]. The gene discussed is CP; the disease is myeloid sarcoma.